-
81
Small Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human Diseases
Published 2015-12-01Subjects: Get full text
Article -
82
Rethinking professional boundaries: the climate crisis and brain health
Published 2025-02-01Subjects: Get full text
Article -
83
Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases
Published 2025-01-01Subjects: Get full text
Article -
84
A network medicine approach to investigating ME/CFS pathogenesis in severely ill patients: a pilot study
Published 2025-02-01Subjects: Get full text
Article -
85
GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
Published 2025-02-01Subjects: Get full text
Article -
86
Graph Neural Networks in Brain Connectivity Studies: Methods, Challenges, and Future Directions
Published 2024-12-01Subjects: Get full text
Article -
87
-
88
Metal mixtures exposure with risk of elevated serum neurofilament light chain concentrations in U.S. general adults, NHANES 2013–2014
Published 2025-01-01Subjects: Get full text
Article -
89
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
Published 2025-01-01Subjects: Get full text
Article -
90
Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases
Published 2025-02-01Subjects: Get full text
Article -
91
-
92
Subthalamic hGAD65 Gene Therapy and Striatum TH Gene Transfer in a Parkinson’s Disease Rat Model
Published 2013-01-01Get full text
Article -
93
Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the MAPT 10+16 mutation
Published 2024-12-01“…Microtubule-associated protein tau is inextricably linked to a group of clinically diverse neurodegenerative diseases termed tauopathies. The ratio balance of the major tau splicing isoform groups (3 R- and 4 R-tau) is critical in maintaining healthy neurons. …”
Get full text
Article -
94
-
95
RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
Published 2012-01-01“…Amyotrophic Lateral Sclerosis (ALS) is an adult onset neurodegenerative disease, which is universally fatal. While the causes of this devastating disease are poorly understood, recent advances have implicated RNA-binding proteins (RBPs) that contain predicted prion domains as a major culprit. …”
Get full text
Article -
96
Hsp70 and Its Molecular Role in Nervous System Diseases
Published 2011-01-01“…The worldwide incidence of neurodegenerative diseases is high. As neurodegenerative diseases disproportionately affect older individuals, disease-related morbidity has increased along with the general increase in longevity. …”
Get full text
Article -
97
Controllability of Functional and Structural Brain Networks
Published 2024-01-01“…Describing the nature of these interactions has been a challenging task yet important for neurodegenerative disease evolution. Fusing modern dynamic graph network theory techniques and control theory applied on complex brain networks creates a new framework for neurodegenerative disease research by determining disease evolution at the subject level, facilitating a predictive treatment response and revealing key mechanisms responsible for disease alterations. …”
Get full text
Article -
98
Meeting Challenges in the Diagnosis and Treatment of Glaucoma
Published 2024-12-01“…Glaucoma, a progressive and multifactorial optic neurodegenerative disease, still poses significant challenges in both diagnosis and management and remains a perpetual enigma [...]…”
Get full text
Article -
99
-
100
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease
Published 2025-01-01“…Both neuroprotective and neurodegenerative roles have been suggested for cystatin C in neurodegenerative disease. In Parkinson’s disease, investigations assessing cystatin C levels in different types of biospecimens such as blood, cerebrospinal fluid, and in vitro models have had conflicting results. …”
Get full text
Article